Stem cell therapy for frailty in older adults
This trial tests a new stem cell treatment given through an IV to see if it is safe and well-tolerated in older adults with mild to moderate frailty. It may help improve strength and energy levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 85 years old.
- You must have mild or moderate frailty (a doctor will confirm this).
- You must weigh between 40 and 90 kg (about 88 to 198 pounds).
- You must be generally healthy otherwise — no severe kidney, liver, heart, or lung disease.
- You must not have a major brain condition like Parkinson's, dementia, or a recent stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment made from stem cells to see if it can improve strength and energy in people with frailty. It may help older adults who feel weak or tired have a better quality of life.
This study tests if a program designed for older, frail hospital patients can prevent loss of ability to do daily tasks. It focuses on physical activity, mental engagement, and nutrition to help you stay independent.
This study tests a new stem cell medicine given through an IV to see if it is safe for older adults with mild to moderate frailty. Frailty causes weakness and tiredness, and this treatment aims to improve overall health and function.
This trial tests a stem cell treatment called HeXell-2020 to see if it is safe and tolerable for older adults with mild to moderate frailty. The goal is to find ways to improve energy, strength, and overall well-being in aging adults.
This study tests an investigational treatment made from special cells (called mesenchymal stromal cells) that might help reduce frailty in older adults. The treatment is given through an IV and aims to improve strength and overall function.
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
Hear when a new Frailty Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.